✦ LIBER ✦

Diagnosis and treatment of 6-pyruvoyl-tetrahydropterin synthase deficiency

✍ Scribed by Haruo Shintaku; Minoru Asada; Yoshitomo Sawada

Book ID: 117545335
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 179 KB
Volume: 22
Category: Article
ISSN: 0387-7604
DOI: 10.1016/s0387-7604(00)00132-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prenatal diagnosis of 6-pyruvoyl tetrahy

Prenatal diagnosis of 6-pyruvoyl tetrahydropterin synthase deficiency in seven subjects

✍ H. Shintaku; K. J. Hsiao; T. T. Liu; T. Imamura; Y. Hase; R. G. Chen; G. Isshiki 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 219 KB

6-Pyruvoyl-tetrahydropterin synthase def

6-Pyruvoyl-tetrahydropterin synthase deficiency with mild hyperphenylalaninemia

✍ Michelle K. Demos; Paula J. Waters; Hilary D. Vallance; Yolanda Lillquist; Nawal 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Hyperphenylalaninemia due to deficiency

Hyperphenylalaninemia due to deficiency of 6-pyruvoyl tetrahydropterin synthase

✍ C. R. Scriver; C. L. Clow; P. Kaplan; A. Niederwieser 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 461 KB

We have identified deficient biopterin synthesis in four probands and one sib with persistent postnatal hyperphenylalaninemia. The metabolic findings were associated with a benign clinical presentation and normal biopterin level in cerebrospinal fluid in the newborn period, indicating the peripheral

Molecular characterization of 6-pyruvoyl

Molecular characterization of 6-pyruvoyl-tetrahydropterin synthase deficiency in Japanese patients

✍ Takuji Imamura; Y. Okano; Haruo Shintaku; Yutaka Hase; Gen Isshiki 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 165 KB

Pseudoexon exclusion by antisense therap

Pseudoexon exclusion by antisense therapy in 6-pyruvoyl-tetrahydropterin synthase deficiency

✍ Sandra Brasil; Hiu Man Viecelli; David Meili; Anahita Rassi; Lourdes R. Desviat; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 404 KB

Antisense oligonucleotide therapy to modulate splicing mutations in inherited diseases is emerging as a treatment option also for metabolic defects. In this article, we report the effect of cellular antisense therapy to suppress pseudoexon activation in primary dermal fibroblasts from patients with

Phenotypic variability, neurological out

Phenotypic variability, neurological outcome and genetics background of 6-pyruvoyl-tetrahydropterin synthase deficiency

✍ V Leuzzi; Ca Carducci; Cl Carducci; S Pozzessere; A Burlina; R Cerone; D Concoli 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 516 KB